Login / Signup

Impact of molecular testing in clinical practice in gynecologic cancers.

Marilyn HuangTegan HunterBrian SlomovitzMatthew P Schlumbrecht
Published in: Cancer medicine (2019)
Molecular profiling in gynecologic cancers often identified at least one actionable mutation; however, only in a minority of these cases was the course of treatment changed. Further studies are needed to elucidate optimal timing for testing to best utilize actionable information.
Keyphrases
  • clinical practice
  • endometrial cancer
  • single molecule
  • single cell
  • healthcare
  • replacement therapy